Immuno-modulatory biomaterials as anti-inflammatory therapeutics

Roisin I Lynch,Ed C Lavelle,Roisin I. Lynch,Ed C. Lavelle
DOI: https://doi.org/10.1016/j.bcp.2021.114890
IF: 6.1
2022-03-01
Biochemical Pharmacology
Abstract:Biocompatible and biodegradable biomaterials are used extensively in regenerative medicine and serve as a tool for tissue replacement, as a platform for regeneration of injured tissue, and as a vehicle for delivery of drugs. One of the key factors that must be addressed in developing successful biomaterial-based therapeutics is inflammation. Whilst inflammation is initially essential for wound healing; bringing about clearance of debris and infection, prolonged inflammation can result in delayed wound healing, rejection of the biomaterial, further tissue damage and increased scarring and fibrosis. In this context, the choice of biomaterial must be considered carefully to minimise further induction of inflammation. Here we address the ability of the biomaterials themselves to modulate inflammatory responses and outline how the physico-chemical properties of the materials impact on their pro and anti-inflammatory properties (Fig. 1).
pharmacology & pharmacy
What problem does this paper attempt to address?